Life Sciences Times

Faeth Therapeutics Expands Leadership Team with Two Senior Appointments

FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Disease Evaluation

Karyopharm Reports $33.4 Million in Q2 Revenue, Plans August Selinexor sNDA Submission

eClinicalWorks, healow Help Maine Health Center Expand Patient Access

athenahealth Expands AI-Native athenaOne Tools to More Than 170,000 Clinicians

Cycle Pharmaceuticals Taps Forma Life Sciences for U.S. Manufacturing of CAVHANZA

Zipalertinib-Chemotherapy Combination Meets Primary Endpoint in Phase 3 Lung Cancer Trial

PhenoNet Gets FDA Clearance to Begin Phase 3 Trial of Inhaled Alzheimer’s Drug

Sumitomo Pharma America Doses First Patient in Phase 1/2a Retinitis Pigmentosa Study

AcuityMD Ranks No. 316 on 2026 Inc. 5000 With 1,061% Revenue Growth